International Journal of Clinical Research

Objective To analyze the role of non-invasive ventilator assisted therapy in neonatal pneumonia. Methods Randomly divide the period from February 2024 to August 2025 for neonatal pneumonia patients admitted to our hospital (N=54). The experimental group received conventional and non-invasive ventilator assisted therapy, while the control group received conventional treatment. Compare indicators such as arterial blood pressure and partial pressure. Results Regarding the relief time of wheezing, improvement time of respiratory status, and improvement time of chest X-ray absorption, the experimental group was shorter than the control group (P<0.05). Arterial oxygen partial pressure and arterial carbon dioxide partial pressure: After treatment, the experimental group had (78.34 ± 9.13) mmHg and (35.02 ± 8.11) mmHg, while the control group had (64.57 ± 8.03) mmHg and (39.23 ± 6.14) mmHg, with significant differences (P<0.05). The total effective rate was 96.3% in the experimental group and 81.48% in the control group, P＜0.05. Complications: experimental group 3.7%, control group 22.22%, P＜0.05. Conclusion Non invasive ventilator-associated therapy for neonatal pneumonia significantly improves symptom relief, blood gas indicators, and efficacy, with very few complications such as heart failure.

Non invasive ventilator; Relief time for wheezing and suffocation; Neonatal pneumonia; Blood gas indicators